2022 Latest Design Chikungunya Igm Test - Recombinant SARS-CoV-2 Nucleocapsid Protein (N-His) – Bioantibody
2022 Latest Design Chikungunya Igm Test - Recombinant SARS-CoV-2 Nucleocapsid Protein (N-His) – Bioantibody Detail:
Product details
Recombinant SARS-CoV-2 Nucleocapsid Protein is produced by Escherichia coli expression system and the target gene Met1-Ala419 is expressed with 6 HIS tag at the N-terminus. Consists of 428 amino acids and predicts a molecular mass of 46.6 kDa.
Properties
| Purity | ≥95% (SDS-PAGE) |
| Molecular Mass | 46.6 kDa |
| Product Buffer | 20mM PB, 150mM NaCl, 10%Glycerol, pH8.0. |
| Storage | Store at -20℃ to -80℃. Avoid multiple freeze/thaw cycles. |
Order Information
| Product Name | Cat. No | Quantity |
| Recombinant SARS-CoV-2 Nucleocapsid Protein (N-His) | AG0046 | Customized |
Product detail pictures:
Related Product Guide:
Our advancement depends on the superior gear ,superb talents and consistently strengthened technology forces for 2022 Latest Design Chikungunya Igm Test - Recombinant SARS-CoV-2 Nucleocapsid Protein (N-His) – Bioantibody , The product will supply to all over the world, such as: Iceland, Swiss, New Delhi, The design, processing, purchasing, inspection, storage, assembling process are all in scientific and effective documentary process , increasing usage level and reliability of our brand deeply, which makes us become superior supplier of the four major product categories shell castings domestically and obtained the customer's trust well.
By Alan from Kuala Lumpur - 2018.11.28 16:25
This manufacturer can keep improving and perfecting products and service, it is in line with the rules of market competition, a competitive company.
By Christine from Provence - 2018.09.21 11:44
Write your message here and send it to us
